From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The big medical news of 2026 is about the big blockbuster drug of 2025. Semaglutide (a.k.a. Ozempic, a.k.a. Wegovy) is now off patent in Canada. In the U.S. and the rest of the world, patent ...

On January 8, 2026, Collegium Pharmaceutical, Inc. issued full-year 2026 guidance, projecting US$805 million to US$825 million in net product revenues and highlighting new authorized generic supply ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Ozempic, pictured in ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making chemical abortion more affordable and accessible to pregnant women who wish to ...

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

U.S President Donald Trump's move to impose 100% tariffs on patented, branded drugs are expected to have a limited impact on India's pharma industry. Most Indian drugmakers sell generic pharmaceutical ...

The Association for Accessible Medicines and the Biosimilars Council have released the 2025 U.S. Generic & Biosimilar Medicines Savings Report. AAM’s annual savings report highlights that generic and ...

July 11 (Reuters) - Novartis (NOVN.S), opens new tab cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug Entresto before its patent ...